Avanos Medical (AVNS) Intangibles (2013 - 2026)

Avanos Medical has disclosed Intangibles across 14 years of filings, most recently posting $114.7 million for Q1 2026.

• Intangibles for Q1 2026 came in at $114.7 million, up 7.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.7 million (up 7.0% YoY), and the FY2025 annual result was $117.8 million, up 4.9% from the prior year.
• Intangibles came in at $114.7 million for Q1 2026 at Avanos Medical, down from $117.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $271.1 million in Q1 2022 to a low of $105.4 million in Q2 2025.
• The 5-year median for Intangibles is $226.2 million (2024), against an average of $196.3 million.
• Across the five-year window, Intangibles surged 78.05% in 2022 and slumped 53.95% in 2025, its largest moves.
• Avanos Medical's Intangibles stood at $234.2 million in 2022, then climbed by 2.26% to $239.5 million in 2023, then slumped by 53.11% to $112.3 million in 2024, then climbed by 4.9% to $117.8 million in 2025, then dropped by 2.63% to $114.7 million in 2026.
• The last three Intangibles figures came in at $114.7 million (Q1 2026), $117.8 million (Q4 2025), and $122.0 million (Q3 2025), per Business Quant data.